Are Beam Therapeutics Inc (NASDAQ: BEAM) Analysts Predicting A Spike?
Beam Therapeutics Inc (NASDAQ:BEAM) shares, rose in value, with the stock price down by -2.86% to the previous day’s close as strong demand from buyers
Beam Therapeutics Inc (NASDAQ:BEAM) shares, rose in value, with the stock price down by -2.86% to the previous day’s close as strong demand from buyers
The trading price of Beam Therapeutics Inc (NASDAQ:BEAM) closed lower on Tuesday, April 02, closing at $30.55, -6.46% lower than its previous close. In examining
Beam Therapeutics Inc (NASDAQ:BEAM) price on Thursday, March 28, fall -2.71% below its previous day’s close as a downside momentum from buyers pushed the stock’s
Beam Therapeutics Inc (NASDAQ:BEAM) concluded the trading at $34.87 on Wednesday, March 20 with a rise of 0.09% from its closing price on previous day.
Beam Therapeutics Inc (NASDAQ:BEAM) traded at $35.41 at close of the session on Friday, March 15, made an upward move of 2.31% on its previous
Beam Therapeutics Inc (NASDAQ:BEAM) shares, rose in value, with the stock price up by 4.39% to the previous day’s close as strong demand from buyers
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.